Long-Term Evaluation of Colestilan in Chronic Kidney Disease Stage 5 Dialysis Patients with Hyperphosphataemia

Publisher： Karger

E-ISSN： 1421-9735|41|4|247-253

ISSN： 0253-5068

Source： Blood Purification, Vol.41, Iss.4, 2015-12, pp. : 247-253

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dialysis Requirement and Long-Term Major Adverse Cardiovascular Events in Patients with Chronic Kidney Disease and Superimposed Acute Kidney Injury

By  

Nephron, Vol. 136, Iss. 2, 2017-03 ,pp. : 95-102

Karger

Access to resources Recommend Favorite

Long-Term Risk of Progressive Chronic Kidney Disease in Patients with Severe Acute Kidney Injury Requiring Dialysis after Coronary Artery Bypass Surgery

By  

Cardiorenal Medicine, Vol. 5, Iss. 3, 2015-04 ,pp. : 157-163

Karger

Access to resources Recommend Favorite

Randomized, Double-Blind, Placebo-Controlled, Withdrawal Study of Colestilan after Dose Titration in Chronic Kidney Disease Dialysis Patients with Hyperphosphatemia

By  

Nephron, Vol. 130, Iss. 4, 2015-07 ,pp. : 229-238

Karger

Access to resources Recommend Favorite

Chronic Fatigue in Long-Term Peritoneal Dialysis Patients

By  

American Journal of Nephrology, Vol. 21, Iss. 6, 2001-12 ,pp. : 479-485

Karger

Access to resources Recommend Favorite

Long-Term Percutaneous Coronary Intervention Outcomes of Patients with Chronic Kidney Disease in the Era of Second-Generation Drug-Eluting Stents

By  

Cardiorenal Medicine, Vol. 7, Iss. 2, 2016-12 ,pp. : 85-95

Karger

Access to resources Recommend Favorite